2 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Enema: new trials by email Literature Review of Enema trials Research Report on Enema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment Tacrolimus Lipid Suspension for enema, Identical Tacrolimus-free Lipid Suspension for Enema - Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate | Phase 2 | Not yet recruiting | Jina Pharmaceuticals Inc. | 150 | 2025-04-01 | 2025-03-12 |
| Faecal Bacteriotherapy for Ulcerative Colitis Faecal bacterial transplantation, Mesalazine 4G Enema - Ulcerative Colitis | Phase 2 | Completed | Institute for Clinical and Experimental Medicine | 61 | 2017-06-19 | 2021-10-01 |
| Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis Colonoscopy, Gastroscopy, Fecal Microbiota - Ulcerative Colitis | Phase 2 | Terminated | Tel-Aviv Sourasky Medical Center | 80 | 2015-07-01 | 2020-06-17 |
| Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation Gastrograļ¬n, enemas - Fecal Impaction | Phase 2 | Unknown | Jinling Hospital, China | 83 | 2015-04-01 | 2017-08-09 |
| Enemas Before Elective Cesarean Section enema - Complications After Cesarean Section | Phase 2 | Completed | Wolfson Medical Center | 130 | 2009-01-01 | 2016-04-04 |
Colitis, Ulcerative (3) · Fecal Impaction (1)
Institute for Clinical and Experimental Medicine (1) · Jina Pharmaceuticals Inc. (1) · Jinling Hospital, China (1) · Tel-Aviv Sourasky Medical Center (1) · Wolfson Medical Center (1)
China (1) · Czechia (1) · Israel (1)
Ning Li, MD (1) · Samuel Lurie, MD (1)